On CORT's first-quarter 2025 earnings call, investors are likely to focus on the sales performance of its Cushing's syndrome drug, Korlym.

Corcept sees 40% growth in 2025 revenue with promising trials, expanded patient base, and strong projections. Read my ...

The FDA has approved Isturisa (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has not been curative.

New research has increased knowledge about how best to manage equines with Cushing’s syndrome — for which the correct veterinarty term is Pituitary Pars Intermedia Dysfunction (PPID) — one of the most ...

Osilodrostat, an oral cortisol synthesis inhibitor, was previously approved for treating adults with Cushing disease, a subtype of Cushing syndrome in which the hypercortisolemia is due to pituitary ...

Clinicians who are unaware of the pseudocondition may mistake elevated cortisol results for signs of true Cushing syndrome ...

With an unwavering commitment to awareness and change, Knueve is shining a light on the dangers of delayed diagnosis because lives depend on it. Knueve’s novel Surviving Cushing's Disease: A Young Man ...

The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option ...

Through compelling storytelling and dedicated advocacy, author Chuck Knueve works to change that narrative, bringing awareness and education to the public to ensure no voice goes unheard. “Surviving ...

Parkinson’s disease is a chronic neurological disorder that mainly affects movement, but it can also impact speech, mood, sleep, and even memory. While medications help manage symptoms ...

Itchy skin, or pruritus, can be a symptom of liver disease. However, not everyone with liver disease experiences itching, and the specific causes of this itching are unknown. Treatment for itching ...